#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Management of hypoglycaemia in everyday clinical practice


Authors: J. Urbanová 1;  L. Brunerová 1;  J. Brož 2
Authors‘ workplace: Univerzita Karlova v Praze ;  3. lékařská fakulta Centrum pro výzkum diabetu, metabolismu a výživy II. interní klinika 3. LF UK a FNKV Přednosta: prof. MUDr. Michal Kršek, CSc. 1;  2. lékařská fakulta Interní klinika 2. LF UK a FN Motol Přednosta: prof. MUDr. Milan Kvapil, CSc., MBA 2
Published in: Prakt. Lék. 2019; 99(2): 57-59
Category: Reviews

Overview

Hypoglycaemia is a side effect primarily of the insulin, sulfonylurea derivates or glinides therapy. Management of hypoglycaemia is based on the immediate ingestion of carbohydrates – preferably glucose, in the recommended amount of 15–20 g. Several recent studies, however, suggest using amount calculated from the patient’s body weight. The therapy of severe hypoglycaemia in the non-professional settings is still based on glucagon injection; in the professional ones the intravenous administration of glucose is the preferable option. Currently studies with the new forms and options of glucagon administration are finishing.

Keywords:

hypoglycaemia – therapy – glucose – glucagon – type 1 diabetes – type 2 diabetes


Sources

1. Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a Workgroup of the American Diabetes Association and The Endocrine Society. Diabetes Care 2013; 36(5): 1384–1395.

2. International Hypoglycemia Study Group. Minimizing hypoglycemia in diabetes. Diabetes Care 2015; 38: 1583–1591.

3. American Diabetes Association. Glycemic targets. Sec. 6. In Standards of medical care in diabetes – 2018. Diabetes Care 2018; 41(Suppl 1): S55–S64.

4. Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2018; 42(Suppl 1): S1–S325.

5. Joint British Diabetes Societies - Inpatient Care Group (JBDS-IP). The hospital management of hypoglycaemia in adults with diabetes mellitus (3rd edition, revised February 2018.

6. Bryden KS, Neil A, Mayou RA, et al. Eating habits, bodyweight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care 1999; 22(12): 1956–1960.

7. McTravish L, Krebs JD, Weatherall M, et al. Weight-based hypoglycaemia treatment protocol for adults with Type 1 diabetes: a randomized crossover clinical trial. Diabet Med 2015; 32(9): 1143–1148.

8. McTravish L, Corley B, Weatherall M, et al. Weight-based carbohydrate treatment of hypoglycaemia in people with Type 1 diabetes using insulin pump therapy: a randomized crossover clinical trial. Diabet Med 2018; 35(3): 339–346.

9. Krebs JD, Weatherall M, Corley B, et al. Optimizing the management of hypoglycaemia in individuals with type 2 diabetes: A randomized crossover comparison of a weight-based protocol compared with two fixed-dose glucose regimens. Diabetes Obes Metab 2018; 20(5): 1256–1261.

10. Brodows RG, Williams C, Amatruda JM. Treatment of insulin reactions in diabetics. JAMA 1984; 252(24): 3378–3381.

11. Slama G, Traynard PY, Desplanque N, et al. The search for an optimized treatment of hypoglycemia. Arch Intern Med 1990; 150(3): 589–593.

12. Wiethop BV, Cryer PE. Alanine and terbutaline in treatment of hypoglycemia in IDDM. Diabetes Care 1993; 16(8): 1131–1136.

13. Husband AC, Crawford S, McCoy LA, et al. The effectiveness of glucose, sucrose, and fructose in treating hypoglycaemia in children with type 1 diabetes. Pediatr Diabetes 2009; 11(3): 154–158.

14. Hall-Boyer K, Zaloga GP, Chernow B. Glucagon: hormone or therapeutic agent? Crit Care Med 1974; 12(7): 584–589.

15. Lee H, Hosein EA. Chronic alcohol feeding and its withdrawal on the structure and function of the rat liver plasma membrane: a study with 125I-labelled glucagon binding as a metabolic probe. Can J Physiol Pharmacol 1982; 60(9): 1171–1176.

16. American Medical Association, Council on Drugs. AMA drug evaluations annual 1994; 1045.

17. Yale JF, Dulude H, Egeth M, et al. Faster use and fewer failures with needle-free nasal gucagon versus injectable glucagon in severe hypoglycemia rescue: a simulation study. Diabetes Technol Ther 2017; 19(7): 423–432.

Labels
General practitioner for children and adolescents General practitioner for adults
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#